Movisse · DIN 02410303 · 0.35 mg · tablets, 28-pack
General benefitMarketed · checked November 18, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Movisse · DIN 02410303
Manufacturer: Mylan Pharmaceuticals ULC; listing date 2016-03-30
Health Canada: Marketed since 2026-07-10 · brand MOVISSE · ATC G03AC01 NORETHISTERONE · form Tablet · route Oral · ingredients NORETHINDRONE 0.35 MG · company Senador laboratories private limited · schedule Prescription
Movisse: Formulary list price $10.99 per unit (the source does not state the unit; exact figure $10.9900). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02410303)
Source record
DIN 02410303: Movisse
Raw flags: sec3=Y
Item: 683200031; group id 802; item number 1963; lccId None; manufacturer id MYL
Source form: Tab-28 Pk; strength: 0.35mg
Recorded listing: General benefit
Source prices (unrounded): $10.9900; ministry $10.9900
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02410303
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=89495
Interchangeable products
Jencycla · DIN 02441306 · $10.9900
Micronor · DIN 00037605 · not recorded
Shortage status: not checked (no credentials)